Neurvati Neurosciences

Neurvati Neurosciences aims to identify, acquire, and develop a range of high-potential technologies targeting various neurological and psychiatric disorders, advancing these technologies through approval and commercialization. The decision to advance projects at Neurvati Neurosciences is based on fundamental analyses of science, clinical data, regulatory pathways, and commercial feasibility. As a Blackstone Life Sciences portfolio company, Neurvati is driven by world-class expertise, relentless passion, and deep resources to optimize the development of neuroscience therapies. The company collaborates with carefully selected strategic partners to expand its operational scope while aligning with patient communities to enhance the development of treatments that can transform patients' lives.